دورية أكاديمية

336O - Biomarker analysis of randomized controlled trial (RCT) of adjuvant chemotherapy (CT) using plasma EBV DNA to identify patients (pts) at higher risk of relapse after radiotherapy (RT) or chemoradiation (CRT) in nasopharyngeal cancer (NPC)

التفاصيل البيبلوغرافية
العنوان: 336O - Biomarker analysis of randomized controlled trial (RCT) of adjuvant chemotherapy (CT) using plasma EBV DNA to identify patients (pts) at higher risk of relapse after radiotherapy (RT) or chemoradiation (CRT) in nasopharyngeal cancer (NPC)
المؤلفون: Hui, E.P., Chan, A.T.C., Ngan, R.K.C., Tung, S.Y., Cheng, A.C.K., Ng, W.T., Lee, V.H., Ma, B., Cheng, H.C., Wong, F.C.S., Loong, H.H., Tong, M., Poon, D.M., Ahuja, A.T., King, A.D., Wang, K., Mo, F., Zee, B.C., Chan, K.C.A., Lo, Y.M.D.
المصدر: In Annals of Oncology November 2017 28 Supplement 10:x100-x100
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1093/annonc/mdx665